Arrowhead Pharmaceuticals Inc. (ARWR)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1. 432,926 $35,855 +7% 9.31%
2.
Farallon Capital

Thomas Steyer

365,000 $30,229 +112% 0.13%
3.
Perceptive Advisors

Joseph Edelman

315,141 $26,100 -24% 0.33%
4.
Marshall Wace LLP

Paul Marshall And Ian Wace

250,380 $20,736 0.09%
5. 214,988 $17,805 -48% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$50.00 500 Director 17,500 2020-10-08 Filing
$50.93 500 Director 17,000 2020-10-08 Filing
$31.33 500 Director 16,500 2020-06-15 Filing
$35.40 500 Director 16,000 2020-04-15 Filing
$23.94 500 Director 15,500 2020-03-16 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$66.09 5,830 Officer, Director 3,279,022 2021-10-22 Filing
$65.57 44,170 Officer, Director 3,284,852 2021-10-22 Filing
$66.23 15,000 Officer, Director 3,329,022 2021-10-20 Filing
$63.76 2,750 Director 9,000 2021-09-13 Filing
$63.76 2,250 Director 11,750 2021-09-13 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 820,328 $51,213 30.37%
2. 123,864 $7,733 0.01%
3. 43,840 $2,737 0%
4. 43,850 $2,653 0%
5. 35,106 $2,192 0.02%
News See All